Message
  • EU e-Privacy Directive

    This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.

    View e-Privacy Directive Documents

G. lucidum (Reishi mushroom) for cancer treatment

There have been an increasing number of patients diagnosed with cancer each year. Certain malignancies have been a major cause of death in some populations. People who have been diagnosed with cancer want to do everything they can to combat the disease, manage its symptoms and cope with the side effects of radio/chemotherapy. Many turn to complementary and alternative medicine. G. lucidum extract is a medication that has been widely used by traditional Chinese medicine (TCM) practitioners for this regard. It is usually recommended as an immune system support supplement in cancer treatment. Latest laboratory research and preclinical trials of G. lucidum have shown promising results of its antitumour activity. However, clinical evidence of its efficacy is sparse and a systematic review is in need to provide collective information for health-care consumers.



Our review identified and subsequently included five relevant randomised controlled trials. A total of 373 subjects were analysed. A meta-analysis was performed to pool available data from individual trials. Our results found that patients with G. lucidum extract in their anticancer regimen were 1.27 times more likely to respond to chemotherapy or radiotherapy than those without. However, the data failed to demonstrate significant effect on tumour shrinkage when it was used alone. In addition, G. lucidum could stimulate host immune functions by considerably increasing CD3, CD4 and CD8 lymphocyte percentages. Nevertheless, natural killer (NK)-cell activity, which has been suggested to be an indicator of self-defence against tumour cell, was marginally elevated. Patients in the G. lucidum group were found to have a relatively better quality of life after treatment than those in the control group. A few cases of minor side effect associated with G. lucidum treatment including nausea and insomnia were reported.

There are limitations of the results from this systematic review. First, most included studies were small and there were concerns on the methodological quality of individual trials. Second, all participants in the individual trials were recruited from the Chinese population. Together, the robustness and applicability of the results were largely affected.

 

http://www.cochrane.org/CD007731/GYNAECA_g-lucidum-reishi-mushroom-cancer-treatment

Hear this article
 
Language Selection
English (United Kingdom)Italian - ItalyDeutsch (DE-CH-AT)Español(Spanish Formal International)French (Fr)
Prossimi Eventi
Cena con Erbe Spontanee D'Estate

IL CASALE DEI BUONI SAPORI

in collaborazione con

CASA DELLE ERBE DELLA TUSCIA E DEL MONTE SORATTE

 

 

Mercoledì 28 Giugno 2017

ore 20.00

 

IL CASALE DEI BUONI SAPORI

Statale Nepesina 311, Loc. Colonnetta - NEPI

 

Info e Prenotazioni Alessandro Sgamuffa

0761 571504  -  338 1385912

 

 

Read more...
Support Cybermed

 

Cybermed ADV
Follow us on

Visitors Counter
mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday10964
mod_vvisit_counterYesterday40019
mod_vvisit_counterThis week50983
mod_vvisit_counterLast week248796
mod_vvisit_counterThis month1269731
mod_vvisit_counterLast month2406870
mod_vvisit_counterAll days99195636

We have: 816 guests, 17 bots online
Your IP: 54.198.201.250
 , 
Today: Jun 27, 2017